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When standard medical therapy is employed, cardiogenic 
shock is associated with an in-hospital mortality rate in 
excess of 75 % . Coronary angioplasty has been shown to re- 
duce this mortality in patients following myocardial 
infarction,’ but the procedure can be complicated by tran- 
sient myocardial ischemia induced by prolonged balloon 
inflation, acute vessel closure, or arrhythmias. To avoid 
possible decompensation during high-risk angioplasty, in- 
tra-aortic balloon counterpulsation and percutaneous car- 
diopulmonary bypass have been used to help support the 
circulation.2-5 Although these devices can provide variable 
degrees of circulatory support, none directly decompress 
the left ventricle and unload the heart throughout the car- 
diac cycle. A new circulatory support device, the Nimbus 
Hemopump (Nimbus Medical Inc., Ranch0 Cordova, Ca- 
lif.), decompresses the left ventricle by withdrawing blood 
directly from the ventricular cavity and ejecting it into the 
descending aorta (Fig. 1). Flow up to 3.5 L/min is generated 
by an Archimedes spiral vane screw rotating at 25,000 rpm. 
We report two patients with cardiogenic shock who were 
successfully supported with the Hemopump during coro- 
nary angioplasties complicated by potentially catastrophic 
arrhythmias. 
Case No. 1. A 48-year-old man with an extensive antero- 
lateral myocardial infraction was treated with tissue plas- 
minogen activator, but developed progressive congestive 
heart failure and hypotension over the ensuing 48 hours. 
Despite inotropic support, the blood pressure (BP) re- 
mained 74/50 mm Hg, pulmonary capillary wedge pressure 
(PCWP) was 37 mm Hg, and the cardiac index (CI) was 2.3 
L/min. The left femoral artery was surgically exposed and 
the 21F Hemopump was advanced into the left ventricle via 
a 12 mm Dacron graft anastomosed to the side of the ves- 
sel. With Hemopump support, BP rose to 96/61 mm Hg, 
PCWP fell to 11 mm Hg, and CI increased to 3.9 L/min. 
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Coronary arteriography was performed from the right 
femoral artery using the Judkins technique. An 8F pigtail 
catheter was advanced to the ascending aorta to avoid 
guide wire entrapment in the Hemopump. Selective coro- 
nary arteriography demonstrated three-vessel coronary 
disease including a 100 % occlusion of the proximal left an- 
terior descending (LAD) coronary artery. During arteriog- 
raphy, the patient developed third-degree heart block with 
a slow ventricular escape rhythm (Fig. 2). Before placement 
of a pacemaker, BP was maintained at 50 mm Hg with 
Hemopump circulatory support. Coronary angioplasty of 
the proximal LAD was then successfully performed using 
an 0.014 inch standard “J” guide wire (USC1 Division of 
C.R. Bard, Billerica, Mass.) and a 3.0 mm balloon dilata- 
tion catheter (“Skinny”, SciMed Life Systems Inc., Maple 
Grove, Minn.). While hemodynamically improved, the pa- 
tient subsequently developed a large nonhemorrhagic fron- 
toparietal cerebral infarction and died on the seventh hos- 
pital day. 
Case No. 2. A 73-year-old man with a chronic ischemic 
cardiomyopathy was transferred with medically refractory 
cardiogenic shock. BP was 90/60 mm Hg, PCWP was 22 
mm Hg, and CI was 1.9 L/min. Cardiac catheterization 
demonstrated a 70% stenosis of the left main (LM) eoro- 
nary artery, 90% stenosis of the mid-LAD, 70% complex 
stenosis of the proximal left circumflex (LCx), and proxi- 
mal occlusion of the right coronary artery. During each 
coronary injection BP fell to 60/40 mm Hg for periods up 
to 30 seconds. Due to depressed left ventricular function, 
surgical revascularization was not attempted. The Hemo- 
pump was placed using the surgical approach described 
above. BP subsequently rose to 98/60 mm Hg, PCWP de- 
creased to 18 mm Hg, and CI increased to 2.8 L/min. Cor- 
onary angioplasties of the LM, LAD, and LCx stenoses 
were successfully performed using the 0.014 inch “J” guide 
wire and a 2.5 mm balloon “Skinny” dilatation catheter. 
During coronary angioplasty, the patient had two episodes 
of sustained ventricular tachycardia lasting 30 seconds and 
120 seconds, respectively, terminated by lidocaine injec- 
tion and discontinuation of inotropic agents. A mean BP of 
48 mm Hg was maintained during each arrhythmia. De- 
spite successful coronary revascularization, severe hemo- 
dynamic compromise persisted and the patient died on the 
ninth hospital day. 
In the present report, successful coronary angioplasty 
was performed in two patients with cardiogenic shock who 
were supported by the Nimbus Hemopump. Systemic ar- 
terial pressure was adequately maintained in each case, 
even during potentially catastrophic arrhythmias. Circula- 
tory assist devices have been advocated as adjunctive ther- 
apy during coronary angioplasty in patients with severe left 
ventricular dysfunction or large regions of potentially 
jeopardized myocardium in the distribution of the target 
vessels. Although circulatory assistance can be provided by 
a variety of devices, the Hemopump offers the unique ad- 
vantage of directly decompressing the left ventricle and 
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Fig. 1. Anteroposterior chest radiograph of patient (Case No. 1) demonstrating the Hemopump with in- 
flow cannula in the left ventricle and pump housing in the descending aortic arch. The flexible drive shaft 
couples the pump to the motor outside the patient’s body. 
Fig. 2. Simultaneous electrocardiogram and hemodynamic recording demonstrating complete atrioven- 
tricular block with a ventricular escape rhythm of 5 to 10 beats/min (Case No. 1). Mean aortic pressure was 
maintained at 50 mm Hg by nonpulsatile flow from the Hemopump. 
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reducing ventricular distension. During regional ischemia 
in animal models, the Hemopump increases collateral per- 
fusion within the risk region.6 Thus the Hemopump may be 
especially useful during transient ischemic episodes com- 
plicating high-risk coronary angioplasty. 
Although the Hemopump has a large 21F profile seated 
across the aortic valve, it did not interfere with routine 
coronary angiography or angioplasty. The Hemopump 
produces little hemolysis or aortic valve trauma, and thus 
may be useful for long-term support.6 Nevertheless, the 
size of the device and the requirement for placement via 
surgical arteriotomy of the femoral artery limit the speed 
of insertion. Furthermore, placement of the distal catheter 
in the left ventricular cavity can mechanically induce ven- 
tricular arrhythmias or dislodge mural thrombus. These 
preliminary findings suggest that circulatory assistance 
using the Nimbus Hemopump may be useful in high-risk 
patients undergoing coronary angioplasty. The long-term 
effect of this device on survival in patients with cardiogenic 
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Routine, temporary pacemaker insertion prior to percuta- 
neous transluminal coronary angioplasty (PTCA) is a 
common practice to prevent asystole and symptomatic 
bradycardia during balloon inflation involving atheroscle- 
rotic lesions of the right and circumflex coronary arteries.’ 
These rhythm abnormalities are usually transient, resolv- 
ing with balloon deflation. New conduction defects follow- 
ing PTCA do occur, but they are infrequent, occurring in 
only 0.9% of National Heart, Lung, and Blood Institute 
(NHLBI) PTCA registry patients2 and in 1.4% of the pa- 
tients undergoing PTCA at Emory University.3 In these 
two reports, the majority of these conduction defects 
resolved during the hospitalization, with none progressing 
to complete heart block requiring a permanent pacemaker. 
We describe a patient who developed delayed complete 
heart block 30 hours following PTCA complicated by side 
branch occlusion. 
The patient was a 68-year-old man with a history of 
smoking, hypertension, and elevated cholesterol who pre- 
sented with a lo-day history of progressive angina with 
electrocardiographic (ECG) changes consistent with ante- 
rior ischemia (Fig. 1, A). He was hospitalized and started 
on medical therapy, with resolution of his chest pain. Se- 
rial cardiac enzyme blood samples for myocardial infarc- 
tion (MI) were negative. He underwent coronary angiogra- 
phy the day following admission, revealing a 95 % mid-left 
anterior descending (LAD) lesion. There was nonocclusive 
disease in the right and circumflex coronary arteries. He 
remained asymptomatic with medical therapy and under- 
went PTCA of the LAD lesion on the sixth hospital day. 
The procedure was performed with a 3 mm Profile Plus 
balloon and 0.014 flexible steerable guide wire (USC1 Di- 
vision of C. R. Bard, Billerica, Mass.). The initial gradient 
across the LAD lesion was 44 mm hg. The balloon catheter 
was positioned distal to the first septal perforator and two 
inflations each at 8 atm for 60 seconds were performed. The 
postdilatation gradient was 2 mm Hg. Final angiography 
following balloon catheter removal showed that the steno- 
sis had been reduced from 95 % to less than 25 ?A. A septal 
branch arising just prior to and not involved in the stenotic 
site was totally occluded (Fig. 2, A and B). The patient ex- 
perienced chest pain following PTCA but repeat injection 
of the left coronary system continued to show the LAD to 
be patent and the first septal perforator to still be occluded. 
The patient’s chest pain resolved with intravenous ni- 
trates. An ECG performed 1 hour following the procedure 
(Fig. 1, B) showed a new right bundle branch block 
(RBBB). Cardiac enzyme values drawn serially over the 
next 24 hours were elevated, with a peak creatine kinase of 
1006 U/L (normal 0 to 200 U/L) and a 14% MB fraction 
(normal 0% to 3 % ). An ECG the following morning (24 
hours after PTCA) showed an RBBB and left anterior fascic- 
ular block (LAFB) (Fig. 1, C). The patient remained asymp- 
tomatic until approximately 1 PM the day after PTCA, 
when he developed lightheadedness associated with a pulse 
rate of 33 beats/min and systolic blood pressure of 90 mm 
Hg. The ECG (Fig. 1, D)) at this time showed complete 
